Aetna to cut pathology reimbursement to 45-50% of Medicare rates

In just a couple of weeks, Aetna will slash its reimbursement for many pathology services to 45-50% of current Medicare prices.  This issue was first discussed in the April edition of Laboratory Economics. These cuts represent yet another significant decline in reimbursement for pathology services.  How much of an impact to the bottom line these cuts will have obviously depends on each laboratory’s payor mix, but they are certainly unwelcome nonetheless.